Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease

NCT02700919 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: BCT197
DRUG: Placebo

Sponsor

Mereo BioPharma